chuminhua2020-06-01 20:30
5/30,Menlo Therapeutics公司$Menlo Therapeutics(MNLO)$ 宣布,美国FDA已批准其全资子公司Foamix Pharmaceuticals开发的米诺环素局部疗法Zilxi(1.5% minocyline,FMX103)上市,治疗酒渣鼻成人患者。新闻稿指出,Zilxi是首款获得美国FDA批准治疗酒渣鼻成人患者的米诺环素局部疗法。Zilxi是该公...查看全文
$Menlo Therapeutics(MNLO)$ 内部交易: 2020-09-08,总裁 and CEO,Domzalski David ,买入,75000普通股, $1.38
$Menlo Therapeutics(MNLO)$ 内部交易: 2020-09-08,CFO,Saik Andrew ,买入,40000普通股, $1.46
$Menlo Therapeutics(MNLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-049795 Size: 5 KB 网页链接
$Menlo Therapeutics(MNLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-049796 Size: 5 KB 网页链接
$Menlo Therapeutics(MNLO)$ 8-K Current report, items 5.03, 7.01, and 9.01 Accession Number: 0001104659-20-102850 Act: 34 Size: 448 KB 网页链接
$Menlo Therapeutics(MNLO)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001104659-20-101640 Act: 34 Size: 232 KB 网页链接
$Menlo Therapeutics(MNLO)$ 内部交易: 2020-08-20,Director,BARBARI SHARON ,期权,75000普通股, $1.48
$Menlo Therapeutics(MNLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-047960 Size: 7 KB 网页链接
$Menlo Therapeutics(MNLO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001566044-20-000011 Act: 34 Size: 7 MB 网页链接
$Menlo Therapeutics(MNLO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001566044-20-000009 Act: 34 Size: 728 KB 网页链接